Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts $2.52 +0.07 (+2.65%) As of 10:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals Earnings Summary Rocket Pharmaceuticals posted Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.56, which topped analysts' consensus estimates of -$0.58 by $0.02. With a trailing EPS of -$2.63, Rocket Pharmaceuticals' earnings are expected to grow next year, from ($2.83) to ($2.22) per share. Upcoming Q2 Earnings DateAug. 4Before Market OpensEstimatedConsensus EPS (May. 13) -$0.58 Actual EPS (May. 13) -$0.56 Beat By $0.02 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)RCKT Upcoming EarningsRocket Pharmaceuticals' next earnings date is estimated for Monday, August 4, 2025, based on past reporting schedules. Powered by Get Rocket Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rocket Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRCKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Rocket Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.84-$0.59-$0.72Q2 20254-$0.79-$0.56-$0.63Q3 20254-$0.81-$0.46-$0.59Q4 20254-$0.77-$0.47-$0.58 FY 2025 14 -$3.21 -$2.08 -$2.52 Q1 20261-$0.27-$0.27-$0.27Q2 20261-$0.07-$0.07-$0.07Q3 20261$0.05$0.05$0.05Q4 20261$0.25$0.25$0.25 Rocket Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/4/2025(Estimated)--------5/13/2025--$0.58-$0.56+$0.02---5/5/2025Q1 2025-$0.59-$0.56+$0.03-$0.56$0.80M-3/3/2025Q4 2024-$0.68-$0.62+$0.06-$0.62$0.03M-11/7/2024--$0.78-$0.71+$0.07-$0.71--8/5/2024Q2 2024-$0.72-$0.74 -$0.02-$0.74--5/6/2024Q1 2024-$0.67-$0.66+$0.01-$0.66--2/26/2024Q4 2023-$0.78-$0.64+$0.14-$0.64--11/6/2023Q3 2023-$0.81-$0.75+$0.06-$0.75--8/10/2023Q2 2023-$0.81-$0.82 -$0.01-$0.82-- Rocket Pharmaceuticals Earnings - Frequently Asked Questions When is Rocket Pharmaceuticals' earnings date? Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 4th, 2025 based off last year's report dates. Learn more on RCKT's earnings history. Did Rocket Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.02. Learn more on analysts' earnings estimate vs. RCKT's actual earnings. How much profit does Rocket Pharmaceuticals generate each year? Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$258.75 million. RCKT has generated -$2.63 earnings per share over the last four quarters. What is Rocket Pharmaceuticals' EPS forecast for next year? Rocket Pharmaceuticals' earnings are expected to grow from ($2.83) per share to ($2.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies CorMedix Earnings Results WAVE Life Sciences Earnings Results Aurinia Pharmaceuticals Earnings Results Enliven Therapeutics Earnings Results AbCellera Biologics Earnings Results Phibro Animal Health Earnings Results Verve Therapeutics Earnings Results Collegium Pharmaceutical Earnings Results Intellia Therapeutics Earnings Results Akebia Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:RCKT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts